Langmuir isotherms and fluorescence and atomic force microscopy images of synthetic model lung surfactants were used to determine the influence of palmitic acid and synthetic peptides based on the surfactant-specific proteins SP-B and SP-C on the morphology and function of surfactant monolayers. Lung surfactant-specific protein SP-C and peptides based on SP-C eliminate the loss to the subphase of unsaturated lipids necessary for good adsorption and respreading by inducing a transition between monolayers and multilayers within the fluid phase domains of the monolayer. The morphology and thickness of the multilayer phase depends on the lipid composition of the monolayer and the concentration of SP-C or SP-C peptide. Lung surfactant protein SP-B and peptides based on SP-B induce a reversible folding transition at monolayer collapse that allows all components of surfactant to be retained at the interface during respreading. Supplementing Survanta, a clinically used replacement lung surfactant, with a peptide based on the first 25 amino acids of SP-B also induces a similar folding transition at monolayer collapse. Palmitic acid makes the monolayer rigid at low surface tension and fluid at high surface tension and modifies SP-C function. Identifying the function of lung surfactant proteins and lipids is essential to the rational design of replacement surfactants for treatment of respiratory distress syndrome.

Endogenous lung surfactant, and lung surfactant replacements used to treat respiratory distress syndrome, can be inactivated during lung edema, most likely by serum proteins. Serum albumin shows a concentration-dependent surface pressure that can exceed the respreading pressure of collapsed monolayers in vitro. Under these conditions, the collapsed surfactant monolayer can not respread to cover the interface, leading to higher minimum surface tensions and alterations in isotherms and morphology. This is an unusual example of a blocked phase transition (collapsed to monolayer form) inhibiting bioactivity. The concentration-dependent surface activity of other common surfactant inhibitors including fibrinogen and lysolipids correlates well with their effectiveness as inhibitors. These results show that respreading pressure may be as important as the minimum surface tension in the design of replacement surfactants for respiratory distress syndrome.

No abstract

Over a range of conditions, lipid and surfactant monolayers exhibit coexistence of discrete solid domains in a continuous liquid. The surface shear viscosity, mu(s), of such monolayers collapses onto a single curve: mu(s)/mu(so) = [1-(A/A(c))](-1), in which mu(so) is the viscosity of the liquid phase, A is the area fraction of the solid phase measured by fluorescence microscopy, and A(c) is a critical solid phase fraction. This scaling relationship is directly analogous to that of three-dimensional dispersion of spheres in a solvent with long-range repulsive interactions, with area fraction replacing volume fraction.

Developing synthetic lung surfactants to replace animal extracts requires a fundamental understanding of the roles of the various lipids and proteins in native lung surfactant. We used Brewster angle microscopy (BAM), atomic force microscopy (AFM), and Langmuir isotherms to study the influence of palmitoyloleoylphosphatidylglycerol (POPG) in monolayers of dipalmitoylphosphatidylcholine and palmitic acid mixtures with or without dSP-B1-25, a peptide dimer based on the first 25 amino acids of surfactant protein B (SP-B). At surface pressures between 30 and 40 mN/m, only monolayers containing POPG and dSP-B1-25 showed plateaus in the isotherm similar to those in Survanta, a bovine extract replacement lung surfactant that contains native SP-B and SP-C proteins. BAM images show distinct morphological changes in the fluid phase during these plateaus, while AFM images of deposited monolayers show that multilayer structures, which we named "nanosilos", form in the fluid phase at the plateau. These nanosilos are from 50 to 300 nm in diameter and from 5 to 8 nm in height and are similar to those observed in deposited Survanta monolayers. We propose that POPG and SP-B interact to stabilize the monolayer composition by trapping POPG in three-dimensional surface-associated aggregates at high surface pressures, preventing the irreversible loss of POPG and SP-B to the subphase.